Can this memo be signed electronically?

Yes. Under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states, electronic signatures are legally enforceable when intent, consent, attribution, and record retention are satisfied.

Is notarization required for the memo?

Not usually. Business Study Memos are internal decision records and rarely require notarization unless a specific attachment or affidavit calls for a notary under state law.

What if signer names don’t match records?

Mismatched names can create attribution issues. Use legal names for signatures, include role/title, and preserve the audit trail showing signer identity and authentication method.

How long should I keep the memo?

Retain according to function: at least 3 years for tax records (IRC §6501(a)), 6 years for HIPAA‑relevant items (45 CFR §164.530(j)), and longer if required by contract or state law.

Who is authorized to sign approvals?

Signatory authority should follow corporate delegations of authority and internal approval matrices; record the title and the authority basis within the memo.

How can I correct errors after signing?

If substantive changes are needed, prepare an amended memo or addendum and obtain fresh approvals. Minor clerical corrections should be tracked with versioning and an explanatory note.

Business Study Memo

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

BUSINESS STUDY MEMO

Client Name:

Consultant Name:

Memo Date:

WHEREAS

WHEREAS, Client Name: (the "Client") desires a formal study and assessment of certain aspects of its business operations, market position, and strategic options; and

WHEREAS, Consultant Name: (the "Consultant") represents that it has the experience and resources necessary to perform the study described herein; and

WHEREAS, the parties wish to set forth the scope, deliverables, payment terms and other material terms governing the performance of the business study in this Business Study Memo (the "Memo").

SCOPE OF WORK

Scope of Study and Activities

DELIVERABLES

Deliverables (reports, presentations, models)

METHODOLOGY

Proposed Methodology and Timeline

PAYMENT TERMS

Total Fixed Fee:

Payment Schedule

Late Payment Fee:

EXPENSES

Reimbursable Expenses Cap:

Expense Reimbursement Procedure

TERM AND TERMINATION

Start Date: End Date:

Termination Notice Period (days):

Termination for Cause

CONFIDENTIALITY

Each party shall maintain as confidential and shall not disclose to any third party any Confidential Information received from the other party. "Confidential Information" includes non-public business, technical, financial and strategic information disclosed in connection with the services and deliverables, except information that (a) is or becomes publicly known other than through breach of this Memo; (b) was rightfully known by the receiving party prior to disclosure; or (c) is independently developed without use of the disclosing party's information.

Confidentiality Duration (years):

INTELLECTUAL PROPERTY AND USE OF DELIVERABLES

Unless otherwise agreed in writing, Consultant grants Client a non-exclusive, non-transferable license to use the final deliverables for Client's internal business purposes. Consultant retains ownership of methodologies and underlying intellectual property. If assignment of intellectual property is required, parties shall document terms and compensation in a written amendment.

LIMITATIONS; NO GUARANTEE

Consultant will exercise reasonable professional care in performing the study but does not guarantee specific business outcomes or financial results. Client acknowledges that projections and recommendations are opinions based on available information and reasonable assumptions.

GOVERNING LAW

This Memo shall be governed by and construed in accordance with the laws of:

ENTIRE AGREEMENT

This Memo, together with any attachments and written amendments executed by both parties, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings and representations, whether written or oral.

ACCEPTANCE, CONTACTS AND APPROVAL

Client Contact Consultant Contact Acceptance Criteria

Client Printed Name:

By:

Date:

Consultant Printed Name:

By:

Date:

What a Business Study Memo Is and When It’s Used

A Business Study Memo is a concise internal document that summarizes research, analysis, and recommended actions for a specific business issue or opportunity. It typically includes background, scope, methodology, findings, financial impact, risks, and a proposed action plan to support decision makers.

Why a Well‑Prepared Business Study Memo Matters

A clear memo documents analysis and rationale, reduces decision risk, and creates a single reference for approvals and audits. It helps stakeholders compare options and ensures consistent communication across finance, operations, and senior leadership.

Typical Teams and Roles That Prepare or Review This Memo

The memo’s audience can include department heads, the C-suite, board committees, and external reviewers such as auditors or lenders.

Business analysts and strategy teams preparing option comparisons for leadership.
Finance and accounting teams validating cost, benefit, and ROI estimates.
Legal or compliance reviewers assessing regulatory or contract impact.

Representative Author and Reviewer Profiles

Senior Business Analyst

A Senior Business Analyst compiles quantitative and qualitative research, produces the financial model and sensitivity analysis, and frames recommendations so executives can weigh tradeoffs and approve resources.

General Counsel

General Counsel or a compliance officer reviews legal exposures, contract obligations, and regulatory constraints noted in the memo and verifies that proposed actions meet statutory and company policy requirements.

Core Sections to Include in a Professional Memo

A complete Business Study Memo follows a predictable structure so readers can find facts and decisions quickly. Each section should be concise and evidence‑based.

Executive Summary

One‑page synopsis presenting the problem, recommended option, expected financial impact, and key risks so decision makers can act without reading the full report.

Scope & Objectives

Clear statement of what the study covers and excludes, the timeframe, and the decision criteria used to evaluate options.

Methodology

Data sources, analysis techniques, and assumptions—documented to allow reproducibility and to clarify limitations of the findings.

Financial Analysis

Cost estimates, revenue projections, cash flow, and sensitivity scenarios with supporting tables and key metrics such as NPV, IRR, and payback.

Risk Assessment

Operational, legal, regulatory, and market risks with likelihood and impact ratings and proposed mitigations for each material risk.

Recommendations & Next Steps

Specific action items, responsible parties, target dates, and any required approvals so the organization can move from analysis to execution.

Step‑by‑Step: Preparing and Circulating the Memo

Follow these steps to create a defensible memo, collect approvals, and preserve an auditable record of the decision.

01

Draft the Memo: Compile background, analysis, and recommendation in a single document for internal review.
02

Attach Supporting Data: Include models, source files, and vendor quotes to substantiate financial claims.
03

Internal Review: Circulate to finance, legal, and operations for factual and compliance checks.
04

Final Approval: Obtain required signatures and record approval dates in the document header.

How Electronic Review and Approval Typically Flows

An efficient eSubmission process reduces delays: prepare, route, authenticate, sign, and store with an audit trail for each step.

Upload Document: Place the final memo and attachments in the signing platform or document repository.
Place Fields: Designate signature, date, and approver fields so reviewers sign in the proper order.
Set Authentication: Choose email verification, SMS code, or stronger methods depending on sensitivity.
Capture Audit Trail: Ensure timestamp, IP, and signer identity are recorded for compliance and recordkeeping.

Recommended Digital Workflow Settings

Configure the workflow to balance signer convenience with required authentication and retention for audit readiness.

Field	Configuration
Signing Order	Sequential or parallel based on approval hierarchy
Authentication	Email verification or SMS OTP for routine memos
Document Retention	Retain signed PDF and audit trail for the retention period
Access Controls	Role-based permissions for view, comment, and sign

Technical Considerations for eSubmission and Storage

Ensure the chosen platform captures signer attribution, stores an immutable audit trail, and exports signed records for long‑term retention.

File Formats: Prefer PDF/A or PDF for signed records
Integrations: Support for Microsoft 365, Google Workspace, and NetSuite speeds routing
Security: AES‑256 at rest and TLS 1.2/1.3 in transit

Typical Timing and Internal Deadlines for a Study Memo

Establish clear milestone dates for draft delivery, review cycles, final approvals, and archival to keep the process on schedule.

Initial Draft Due:

Deliver the first draft to stakeholders within the agreed study timeframe

Internal Review Window:

Allow 3–7 business days for finance and legal review depending on complexity

Approval Deadline:

Set a target approval date to align with budget or board cycles

Implementation Start:

Define when recommended actions must begin after approval

Archive Date:

Record finalization and retention start date for compliance

Common Preparation Mistakes to Avoid

Overly long executive summaries that bury the recommendation and impede quick decision making.
Unverified financial inputs or undocumented assumptions that lead to inaccurate ROI and undermine credibility.
Missing approvals or unclear signatory authority, which can delay execution and create governance gaps.
Inadequate version control or failure to attach supporting data, complicating audits and future reviews.

Key Risks and Potential Consequences of Errors

Incorrect Tax Filing: May trigger IRC §6721 penalties for related information returns

I‑9 Documentation: Errors can result in 8 CFR §274a.2 enforcement fines

HIPAA Noncompliance: Leads to regulatory penalties when PHI handling is required

Contractual Breach: Inaccurate facts may create exposure under indemnity clauses

Invalid Signature: Improper attribution or format can jeopardize enforceability

Retention Failures: Missing records may impair audits or regulatory responses

Security and Compliance Elements to Capture

Encryption: AES-256 at rest

Transport Security: TLS 1.2/1.3 in transit

Audit Trail: Timestamp, IP, and action log

Access Controls: Role-based permissions

Certifications: SOC 2 Type II; ISO 27001

HIPAA: BAA required for PHI

Representative eSignature Pricing and Feature Comparison

Basic pricing and common capabilities for selected vendors to consider when choosing a platform for signing and storing Business Study Memos.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Frequently Asked Questions About the Business Study Memo

Answers to common questions about signing, validity, storage, and correction to reduce processing delays and legal uncertainty.

Need help? Contact support

Can this memo be signed electronically?
Yes. Under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states, electronic signatures are legally enforceable when intent, consent, attribution, and record retention are satisfied.
Is notarization required for the memo?
Not usually. Business Study Memos are internal decision records and rarely require notarization unless a specific attachment or affidavit calls for a notary under state law.
What if signer names don’t match records?
Mismatched names can create attribution issues. Use legal names for signatures, include role/title, and preserve the audit trail showing signer identity and authentication method.
How long should I keep the memo?
Retain according to function: at least 3 years for tax records (IRC §6501(a)), 6 years for HIPAA‑relevant items (45 CFR §164.530(j)), and longer if required by contract or state law.
Who is authorized to sign approvals?
Signatory authority should follow corporate delegations of authority and internal approval matrices; record the title and the authority basis within the memo.
How can I correct errors after signing?
If substantive changes are needed, prepare an amended memo or addendum and obtain fresh approvals. Minor clerical corrections should be tracked with versioning and an explanatory note.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now